Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.
Clinical trial NCT01840410 · COMPLETED
Trial details
- NCT number
- NCT01840410
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-11-01
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.